Today, the MAPRx Coalition and 28 of its members, national organizations representing patients, caregivers, and healthcare professionals, submitted a letter to the Senate Finance Committee on their recently released legislation, The 2019 Prescription Drug Pricing Reduction Act of 2019. The Coalition…
On June 6, MAPRx and 45 national advocacy organizations submitted a letter to leadership in the House of Representatives’ Ways and Means Committee and Energy and Commerce Committee with recommendations for improving Medicare Part D. Among other improvements, the letter…
Medicare Access for Patients Rx (MAPRx), a coalition of over 55 patient advocacy organizations, today hosted a summit to celebrate the 15th anniversary of Medicare Part D. The event included panel discussions featuring policymakers, health care thought leaders, and patient…
Today, George W. Bush, 43rd President of the United States, spoke at a summit celebrating the 15th anniversary of Medicare Part D. The event was hosted by MAPRx – a coalition convened by the Lupus Foundation of America (LFA) consisting…
Study Finds Popular Prescription Drug Benefit Program Faces Challenges A new report released today on Medicare Part D found the program is as popular and robust as ever, but faces challenges that could result in increased costs and limited access…
The Medicare Access for Patients Rx (MAPRx) Coalition, comprised of more than fifty-five beneficiary advocacy organizations, urges the Centers for Medicare and Medicaid Services (CMS) to reverse its proposed policy changes to the Medicare Part D six “protected classes.” Proposed…
Letter to Congress applauds Medicare coverage of drugs, new report highlights economic impact WASHINGTON, D.C., December 3, 2013 – The Medicare Access for Patients Rx Coalition (MAPRx) today distributed a letter and a report to Congress signed by 53 national…